Rheumatoid arthritis, a complex multifactorial disease: On the way toward individualized medicine
暂无分享,去创建一个
Reinhard Guthke | Hans-Jürgen Thiesen | M. Glocker | R. Guthke | H. Thiesen | Michael O Glocker | J. Kekow | Jörn Kekow
[1] A. Kang,et al. Autoimmunity to type II collagen an experimental model of arthritis , 1977, The Journal of experimental medicine.
[2] M. Dallman,et al. Immunisation against heterologous type II collagen induces arthritis in mice , 1980, Nature.
[3] R. Wells,et al. Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[5] G. Burmester,et al. Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity , 1998, Zeitschrift für Rheumatologie.
[6] M. Bantscheff,et al. Probing the Tertiary Structure of Multidomain Proteins by Limited Proteolysis and Mass Spectrometry , 1998 .
[7] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[8] Kraan,et al. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA) , 1999, Clinical and experimental immunology.
[9] Eric Mjolsness,et al. From Coexpression to Coregulation: An Approach to Inferring Transcriptional Regulation among Gene Classes from Large-Scale Expression Data , 1999, NIPS.
[10] A. Kavanaugh. An overview of immunomodulatory intervention in rheumatoid arthritis. , 1999, Drugs of today.
[11] S. Nakano,et al. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. , 1999, Clinical and experimental rheumatology.
[12] Nello Cristianini,et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..
[13] N. Wulffraat,et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[14] P. Petrow,et al. Cathepsin B and its endogenous inhibitor cystatin C in rheumatoid arthritis synovium. , 2000, The Journal of rheumatology.
[15] Masanori Arita,et al. Metabolic reconstruction using shortest paths , 2000, Simul. Pract. Theory.
[16] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Schrader,et al. Peptidomics technologies for human body fluids. , 2001, Trends in biotechnology.
[18] Neal S. Holter,et al. Dynamic modeling of gene expression data. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Schrader,et al. Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. , 2012, Combinatorial chemistry & high throughput screening.
[20] J. Kos,et al. Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis. , 2001, Biochemical and biophysical research communications.
[21] J. Reginster,et al. WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis. , 2001, Rheumatology.
[22] E. Purisima,et al. Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities. , 2001, Biochemistry.
[23] S. Bowman,et al. How many patients are eligible for anti-TNF therapy in the UK? , 2001, Rheumatology.
[24] U. Lehmann,et al. Quantitative Analysis of Promoter Hypermethylation in Laser-Microdissected Archival Specimens , 2001, Laboratory Investigation.
[25] Hans-Jürgen Thiesen,et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis , 2002, Electrophoresis.
[26] E. Davidson,et al. Modeling transcriptional regulatory networks. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[27] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[28] S. Ibrahim,et al. Gene-expression profile of collagen-induced arthritis. , 2002, Journal of autoimmunity.
[29] Wei Pan,et al. A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments , 2002, Bioinform..
[30] A. Zwinderman,et al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. , 2002, Arthritis and rheumatism.
[31] L. Juliano,et al. Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides. , 2002, The Biochemical journal.
[32] J. Doyle,et al. Reverse Engineering of Biological Complexity , 2002, Science.
[33] J. Kekow,et al. Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor β levels in rheumatoid arthritis , 2002, Annals of the rheumatic diseases.
[34] Wei-Min Liu,et al. Robust estimators for expression analysis , 2002, Bioinform..
[35] Lawrence Steinman,et al. Autoantibody profiling for the study and treatment of autoimmune disease , 2002, Arthritis research.
[36] U. Lehmann,et al. Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. , 2002, Cancer research.
[37] J. Kekow,et al. Diagnostik und Therapiemonitoring mit Methoden der molekularen Medizin , 2002, Zeitschrift für Rheumatologie.
[38] I Petersen,et al. Grading of chronic synovitis--a histopathological grading system for molecular and diagnostic pathology. , 2002, Pathology, research and practice.
[39] Reinhard Guthke,et al. Knowledge-based assessment of gene expression data from chemiluminescence detection. , 2002, Journal of biotechnology.
[40] H. Schlüter,et al. Detection of protease activities with the mass-spectrometry-assisted enzyme-screening (MES) system , 2003, Analytical and bioanalytical chemistry.
[41] Yoav Benjamini,et al. Identifying differentially expressed genes using false discovery rate controlling procedures , 2003, Bioinform..
[42] P. Lorenz,et al. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis , 2003, Arthritis research & therapy.
[43] M. Bantscheff,et al. Proteome Analysis of Diseased Joints from Mice Suffering from Collagen-Induced Arthritis , 2003, Clinical chemistry and laboratory medicine.
[44] Masanori Arita. In silico atomic tracing by substrate-product relationships in Escherichia coli intermediary metabolism. , 2003, Genome research.
[45] D. Brömme,et al. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L. , 2003, European journal of biochemistry.
[46] David Ward,et al. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data , 2003, Bioinform..
[47] P. Lorenz,et al. From transcriptome to proteome: Differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies , 2003, Proteomics.
[48] Ezio Bartocci,et al. Expressionview: visualization of quantitative trait loci and gene-expression data in Ensembl , 2003, Genome Biology.
[49] M. Glocker,et al. Matrix‐assisted laser desorption/ionization‐ quadrupole ion trap‐time of flight mass spectrometry sequencing resolves structures of unidentified peptides obtained by in‐gel tryptic digestion of haptoglobin derivatives from human plasma proteomes , 2003, Proteomics.
[50] J. Epplen,et al. Complex genetic predisposition in adult and juvenile rheumatoid arthritis , 2004, BMC Genetics.
[51] Doulaye Dembélé,et al. Fuzzy C-means Method for Clustering Microarray Data , 2003, Bioinform..
[52] P. Lipsky,et al. New concepts in the treatment of rheumatoid arthritis. , 2003, Annual review of medicine.
[53] Walter Schubert,et al. Topological proteomics, toponomics, MELK-technology. , 2003, Advances in biochemical engineering/biotechnology.
[54] L. Moreland,et al. Upcoming biologic agents for the treatment of rheumatic diseases , 2003, Current opinion in rheumatology.
[55] Seung-Heon Hong,et al. Madimadi, Korean folk medicine, blocks TNF-α, IL-1β, and IL-8 production by activated human immune cells , 2004 .
[56] M. Spillantini,et al. Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation? , 2004, Rheumatology International.
[57] Robert Gentleman,et al. matchprobes: a Bioconductor package for the sequence-matching of microarray probe elements , 2004, Bioinform..
[58] S. Ibrahim,et al. 4th meeting of the EU research network EUROME: From the identification of genes and cellular networks in murine models of arthritis to novel therapeutic intervention strategies in rheumatoid arthritis, London, UK, 9 March 2004 , 2004, Arthritis research & therapy.
[59] H. Thiesen,et al. Identification of new quantitative trait loci in mice with collagen-induced arthritis. , 2004, Arthritis and rheumatism.
[60] O. Meyer,et al. NADPH Oxidase Priming and p47phox Phosphorylation in Neutrophils from Synovial Fluid of Patients with Rheumatoid Arthritis and Spondylarthropathy , 2002, Inflammation.
[61] L. Klareskog,et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial , 2004, The Lancet.
[62] M. Glocker,et al. Mass spectrometric protein structure characterization reveals cause of migration differences of haptoglobin α chains in two‐dimensional gel electrophoresis , 2004, Proteomics.
[63] Lisa M. D'Souza,et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution , 2004, Nature.
[64] P. Miossec. An update on the cytokine network in rheumatoid arthritis , 2004, Current opinion in rheumatology.
[65] O. Fiehn. Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.
[66] D. Hochstrasser,et al. Industrial‐scale proteomics: From liters of plasma to chemically synthesized proteins , 2004, Proteomics.
[67] S. L. Bridges. Genetic markers of treatment response in rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[68] M. Glocker,et al. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. , 2004, Pathology, research and practice.
[69] Marcel Dettling,et al. BagBoosting for tumor classification with gene expression data , 2004, Bioinform..
[70] R. Christopher,et al. Data‐Driven Computer Simulation of Human Cancer Cell , 2004, Annals of the New York Academy of Sciences.
[71] M. Glocker,et al. High Detection Sensitivity Achieved with Cryogenic Detectors in Combination with Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry , 2004, European journal of mass spectrometry.
[72] Reinhard Guthke,et al. Dynamic network reconstruction from gene expression data applied to immune response during bacterial infection , 2005, Bioinform..